From Our Partners
Wednesday, June 29, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

DoD Opens Second Innovation Hub, Emphasizes Biosciences

by Global Biodefense Staff
July 27, 2016
Defense Innovation Unit Experimental (DIUx)

Defense Secretary Ash Carter opens the DoD's second Defense Innovation Unit Experiment office in Boston, July 26, 2016. Credit: DoD

Defense Innovation Unit Experimental (DIUx)
Defense Secretary Ash Carter opens the DoD’s second Defense Innovation Unit Experiment office in Boston, July 26, 2016. Credit: DoD

The U.S. Department of Defense (DoD) this week rolled out the its second Defense Innovation Unit Experimental (DIUx), a new office in Boston that joins its west coast counterpart established last year in Silicon Valley. The offices serve as an innovation hub and model for outreach to innovative technology communities.

The two DIUx hubs strategically place the department in a position to access leading-edge technologies, scientists and other experts.

“Over the last 11 months since we first opened the doors of the West Coast office in Silicon Valley, DIUx … has helped us connect with hundreds of entrepreneurs and firms, making great progress in putting commercially based innovation into the hands of America’s soldiers, sailors, airmen and Marines,” said Defense Secretary Ash Carter.

The DIUx hubs will report directly to the Carter’s office, maintain its own contracting capability abd budget resources.

The leadership team for the hub includes Chief Science Officer Bernadette Johnson, former chief technology officer at MIT Lincoln Laboratories, and Boston military lead Col. Mike McGinley, a lawyer and reservist specializing in cybersecurity.

The DIUx operating structure consists of three teams:

  • Venture Team – identifies emerging commercial technologies and explore their battlefield potential
  • Foundry Team – identifies technologies that require development or adaptation for military applications
  • Engagement Team – introduces innovators to national security challenges and the military to entrepreneurs

Carter said he also wants DoD to be part of the coming revolution in biotechnology and the biosciences, because both can have an impact on the health and welfare of the department’s men and women in uniform.

“That’s why I’m also announcing that DIUx is exploring ways to bring leading minds in the military and DoD who work on biodefense and biological technology together with world-class academic researchers, biotech companies, and entrepreneurs — including those right here in Boston, like [MIT mathematician and geneticist] Eric Lander and the Broad Institute and others,” the secretary added.

Like San Francisco, Austin, Seattle and other places, said Carter, Boston is an ecosystem of companies, universities and research institutions that exemplifies America’s innovative culture, especially in the union of biosciences, engineering and data, areas that together could yield new ways to fight infectious diseases or help develop new materials that can regenerate, respond to their environment or learn and evolve.

A high return on investment will mean improved warfighter capability, with innovative technologies being demonstrated and incorporated into regular defense acquisition programs of record, the secretary said. “That will require more companies that might not look for defense business getting into our game, and also established defense companies having more access to talent,” Carter added.

Source: Cheryl Pellerin, DoD News, edited for context and format by Global Biodefense.

From Our Partners
Tags: Healthcare Cybersecurity

Related Posts

BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs
Health Security

Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs

May 4, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC